Dietary Components Promoting Glp-1 Secretion And Bone Density

Emerging areas for more study include dietary modulation of endogenous GLP-1, strategies to improve compliance, nutritional priorities for weight maintenance post-cessation, combination or staged intensive lifestyle management, and diagnostic criteria for clinical obesity.

During GLP-1 use, nutritional and medical management of gastrointestinal side effects is critical, as is navigating altered dietary preferences and intakes, preventing nutrient deficiencies, preserving muscle and bone mass through resistance training and appropriate diet, and complementary lifestyle interventions.

The results presented in this review highlight the potential of nutritional and physiologic stimulation of GLP-1 secretion. Further research on fasting and postprandial GLP-1 concentrations and the resulting metabolic consequences under different metabolic conditions is needed.

Notably, PYY has a strong bone resorption-promoting effect. In addition, gut microbiota (GM) plays an important role in maintaining bone homeostasis. This review outlines the roles of GLP-1, GLP-2, GIP, and PYY in bone metabolism and discusses the roles of gut hormones and the GM in regulating bone homeostasis and their potential mechanisms.

Secondary bile acids stimulate GLP-1 secretion. Secondary BAs occur under the action of the gut microbiota, which means that alterations in the gut microbiota may change the composition of the BA pool.

The secretion of GLP-1 is closely linked to nutrient sensing by L-cells in the distal small intestine and colon.The interplay between dietary fibre, gut microbiota, and GLP-1 secretion exemplifies the complex synergy underlying metabolic health.